Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q1 2018 · 10-Q
Revenue—
Net Income-$1.82M-$1.82MN/M vs Q1 2017 EPS Diluted-$0.21-$0.21N/M vs Q1 2017 Operating Income-$1,828,343N/M Operating Cash Flow-$1,666,803N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,666,803N/M ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end